AFIB Stock Summary and Trading Ideas (Acutus Medical | NASDAQ:AFIB)

Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.

Acutus Medical trades on the NASDAQ stock market under the symbol AFIB.

As of April 17, 2024, AFIB stock price was flat at $0.16 with 55,866 million shares trading.

AFIB has a beta of -0.32, meaning it tends to be less sensitive to market movements. AFIB has a correlation of 0.00 to the broad based SPY ETF.

AFIB has a market cap of $4.80 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AFIB stock traded as high as $18.00 and as low as $.16.

The top ETF exchange traded funds that AFIB belongs to (by Net Assets): VXF.

AFIB has underperformed the market in the last year with a price return of -76.3% while the SPY ETF gained +22.5%. AFIB has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.0% and -8.8%, respectively, while the SPY returned +6.3% and -3.6%, respectively.

AFIB support price is $.15 and resistance is $.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AFIB stock will trade within this expected range on the day.